Monday’s buzzing with two med-related SPAC deals. Convert and PIPE action. And the rest of the day’s news in SPACs.
Boardroom Alpha Research
DA for LMAO and SeaStar Medical
Ending the week with a deal announcement for LMAO and SeaStar Medical. And the rest of the day’s news in SPACs.
SPAC Redemptions Continue to Trend Lower
An updated look at redemption trends for the month of April. Deadline extensions for FOXW and GRCY. And the rest of the day’s news in SPACs.
Yotta Acquisition Prices $100M IPO
SPAC IPO for Yotta, convert for SWAG and the rest of the day’s news in SPACs.
SPAC Deal for Bull Horn and Cancer Cell Therapy Specialist Coeptis Therapeutics
SPAC Deal for BHSE and cancer cell therapy biopharma Coeptis. Merger votes for Tempo Automation and Telesign. And the rest of the day’s news in SPACs.
Origin Materials on Paving the Way Toward a Carbon Negative Future
John Bissell and Rich Riley, Co-CEOs of Origin Materials (ORGN) tell us how bioplastics are ready and able to reduce our reliance on fossil fuels.
Third Time’s a Charm for ESSC
ESSC announces DA with ICONIQ, its third after terminating with both JDS and Ufin Holdings. DUNE heads to court with its merger target. And the rest of the day’s news in SPACs.
SeatGeek-Redball IPO in the Spotlight
RBAC amended its S-4 for its merger with ticketing tech provider SeatGeek. Redemption update at GLSPT. And the rest of the day’s news in SPACs.
ALAC Breaks up with SolarMax
Adding to the wave of deal terminations, Alberton Acquisition Corp. (ALAC) intends to terminate its merger with SolarMax. And the rest of the day’s news in SPACs.
Danimer Scientific’s CEO on How Bioplastics Can Help Save the World
Boardroom Alpha talks to Steve Croskrey, CEO of Danimer Scientific (DNMR), on why bioplastics technology is ready for takeoff and how the company is moving the world toward a carbon negative future.